Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2016-04-19 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
公司章程（2015年8月）
Governance Information Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司公司章程" which translates to "Cachet Pharmaceutical Co., Ltd. Articles of Association" or "Company Charter." It contains detailed chapters on company governance, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and procedures for shareholder meetings. The content is focused on the internal rules, structure, and governance practices of the company rather than financial results or announcements. There is no indication that this is an annual report, earnings release, or any other financial statement. It is a governance document outlining the company's bylaws and operational framework. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2016-04-19 Chinese
关于公司董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, specifically a board member stepping down from their position. It includes details about the resignation date, the director's name, and the impact on the board composition. There is no financial data, no mention of a report or meeting materials, and it is not a regulatory certification or voting result. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2016-04-19 Chinese
关于投资设立控股子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's investment to establish a controlling subsidiary. It details the investment amount, partners, purpose, risks, and approvals related to the new subsidiary. There is no financial data, no report or financial statements, and no mention of a meeting or voting results. The document is a formal announcement of a capital investment decision, not a full financial report or regulatory filing. This fits best under Capital/Financing Update (CAP) as it concerns company fundraising and capital structure changes through investment in a subsidiary.
2016-04-19 Chinese
关于召开2015年度股东大会的通知公告（已取消）
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2015 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司, including the date, time, location, voting procedures (both onsite and online), agenda items to be discussed and voted on, and instructions for shareholders on how to register and vote. It includes agenda items such as the 2015 annual work reports, financial reports, profit distribution plan, annual report and its summary, social responsibility report, and other proposals. The document also contains an authorization proxy form for shareholders to delegate voting rights. The document is not the actual annual report or financial statements but a formal announcement and notice for the AGM, detailing how the meeting will be conducted and how shareholders can participate and vote. The length is about 5970 characters, which is consistent with a detailed AGM notice. Therefore, this document fits the category of AGM Information (AGM-R).
2016-04-19 Chinese
第五届董事会第五次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fifth meeting of the fifth board of directors of 嘉事堂药业股份有限公司, held on April 18, 2016. It includes approvals of various reports such as the 2015 annual work report, internal control self-evaluation report, 2015 financial statements, profit distribution plan, 2015 annual report and its summary, social responsibility report, and other corporate governance matters. The document repeatedly states that these reports need to be submitted to the shareholders' meeting for approval and provides references to where the full reports can be found (e.g., on 巨潮资讯网). The document itself does not contain the full annual report or detailed financial statements but rather the board's resolutions and approvals related to these reports. The document length is 3596 characters, which is relatively short and consistent with an announcement of board meeting resolutions rather than the full annual report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of board meeting resolutions and related corporate governance matters, not the full annual report or financial report itself.
2016-04-19 Chinese
2015年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the 2015 annual report summary of 嘉事堂药业股份有限公司, containing detailed financial data for the year 2015, including revenue, net profit, assets, and shareholder information. It includes management discussion and analysis, business overview, accounting data, and changes in consolidated entities. The document is approximately 8,795 characters long, which is substantial and contains actual financial statements and analysis, not just an announcement or a certification. The content matches the characteristics of an Annual Report (10-K) as it covers the full fiscal year, detailed financial performance, business operations, and management commentary. Therefore, the appropriate classification is Annual Report (10-K). FY 2015
2016-04-19 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.